| 摘要 |
The invention relates to the use of (1alpha.2beta,4beta.5alpha.7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4] nonane salts for preparing a pharmaceutical composition for the prevention and treatment of diseases associated with inflammation.
|
